메뉴 건너뛰기




Volumn 55, Issue 2, 2013, Pages 143-145

Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation

Author keywords

Cell surface molecules; DC SIGN; Dendritic cells; Glycans; Human; Rodent; Skin

Indexed keywords

GLYCAN; LECTIN; LECTIN RECEPTOR; MONOCLONAL ANTIBODY; VACCINE;

EID: 84875633828     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.10.031     Document Type: Review
Times cited : (101)

References (5)
  • 1
    • 84867637264 scopus 로고    scopus 로고
    • Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells
    • García-Vallejo J.J., Ambrosini M., Overbeek A., et al. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Molecular Immunology 2013, 53(4):387-397.
    • (2013) Molecular Immunology , vol.53 , Issue.4 , pp. 387-397
    • García-Vallejo, J.J.1    Ambrosini, M.2    Overbeek, A.3
  • 3
    • 45549105692 scopus 로고    scopus 로고
    • Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection
    • Schaefer M., Reiling N., Fessler C., et al. Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection. Journal of Immunology 2008, 180(10):6836-6845.
    • (2008) Journal of Immunology , vol.180 , Issue.10 , pp. 6836-6845
    • Schaefer, M.1    Reiling, N.2    Fessler, C.3
  • 4
    • 70450277084 scopus 로고    scopus 로고
    • Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
    • Singh S.K., Stephani J., Schaefer M., et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Molecular Immunology 2009, 47(2-3):164-174.
    • (2009) Molecular Immunology , vol.47 , Issue.2-3 , pp. 164-174
    • Singh, S.K.1    Stephani, J.2    Schaefer, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.